MEG3 can be used as a promising target for cancer diagnosis, prognosis and treatment; however, more fundamental work such as efforts to reduce immune response, minimize off-targets effects, and develop more effective targeted deliver system is needed in order to further develop possible clinical applications. This evidence concerns the gene MEG3 and cancer.